Natural products as anticancer agents: Current status and future perspectives

A Naeem, P Hu, M Yang, J Zhang, Y Liu, W Zhu… - Molecules, 2022 - mdpi.com
Natural products have been an invaluable and useful source of anticancer agents over the
years. Several compounds have been synthesized from natural products by modifying their …

Cell death in photodynamic therapy: From oxidative stress to anti-tumor immunity

C Donohoe, MO Senge, LG Arnaut… - … et Biophysica Acta (BBA …, 2019 - Elsevier
Photodynamic therapy is a promising approach for cancer treatment that relies on the
administration of a photosensitizer followed by tumor illumination. The generated oxidative …

Therapeutic vaccines for cancer: an overview of clinical trials

I Melero, G Gaudernack, W Gerritsen, C Huber… - Nature reviews Clinical …, 2014 - nature.com
The therapeutic potential of host-specific and tumour-specific immune responses is well
recognized and, after many years, active immunotherapies directed at inducing or …

Cancer immunotherapy via dendritic cells

K Palucka, J Banchereau - Nature Reviews Cancer, 2012 - nature.com
Cancer immunotherapy attempts to harness the power and specificity of the immune system
to treat tumours. The molecular identification of human cancer-specific antigens has allowed …

[PDF][PDF] The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures

J Galon, HK Angell, D Bedognetti, FM Marincola - Immunity, 2013 - cell.com
Numerous analyses of large patient cohorts identified specific patterns of immune activation
associated with patient survival. We established these as the immune contexture …

[PDF][PDF] Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance

L Zitvogel, L Galluzzi, MJ Smyth, G Kroemer - Immunity, 2013 - cell.com
Conventional chemotherapeutics and targeted antineoplastic agents have been developed
based on the simplistic notion that cancer constitutes a cell-autonomous genetic or …

[HTML][HTML] Classification of current anticancer immunotherapies

L Galluzzi, E Vacchelli, JM Bravo-San Pedro, A Buqué… - Oncotarget, 2014 - ncbi.nlm.nih.gov
During the past decades, anticancer immunotherapy has evolved from a promising
therapeutic option to a robust clinical reality. Many immunotherapeutic regimens are now …

Cell‐based delivery systems: emerging carriers for immunotherapy

Z Li, Y Wang, Y Ding, L Repp… - Advanced Functional …, 2021 - Wiley Online Library
Immunotherapy is leading a paradigm shift in the treatment of various diseases, including
tumors, auto‐immune diseases, and infectious diseases. However, the limited response rate …

Injectable cryogel-based whole-cell cancer vaccines

SA Bencherif, R Warren Sands, OA Ali, WA Li… - Nature …, 2015 - nature.com
A biomaterial-based vaccination system that uses minimal extracorporeal manipulation
could provide in situ enhancement of dendritic cell (DC) numbers, a physical space where …

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

J Galon, D Bruni - Nature reviews Drug discovery, 2019 - nature.com
Immunotherapies are the most rapidly growing drug class and have a major impact in
oncology and on human health. It is increasingly clear that the effectiveness of …